193 related articles for article (PubMed ID: 9375280)
21. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness.
Stephenson AL; Mackenzie IR; Levy RD; Road J
Thorax; 2001 Jan; 56(1):82-4. PubMed ID: 11120911
[TBL] [Abstract][Full Text] [Related]
22. Orthopaedic manifestations of chronic graft-versus-host disease.
Beredjiklian PK; Drummond DS; Dormans JP; Davidson RS; Brock GT; August C
J Pediatr Orthop; 1998; 18(5):572-5. PubMed ID: 9746402
[TBL] [Abstract][Full Text] [Related]
23. Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin and methotrexate.
Blanche P; Dreyfus F; Sicard D
Clin Exp Rheumatol; 1995; 13(3):377-9. PubMed ID: 7554569
[TBL] [Abstract][Full Text] [Related]
24. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Couriel DR; Beguelin GZ; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja MA; Anagnostopoulos A; Champlin R
Bone Marrow Transplant; 2002 Oct; 30(8):543-6. PubMed ID: 12379897
[TBL] [Abstract][Full Text] [Related]
25. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy.
Grundmann-Kollmann M; Behrens S; Gruss C; Gottlöber P; Peter RU; Kerscher M
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):134-6. PubMed ID: 10607334
[TBL] [Abstract][Full Text] [Related]
26. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?
Burger J; Gmür J; Bruckner-Tuderman L
Bone Marrow Transplant; 1992 Feb; 9(2):139-41. PubMed ID: 1571712
[TBL] [Abstract][Full Text] [Related]
27. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases.
Janin A; Socie G; Devergie A; Aractingi S; Esperou H; Vérola O; Gluckman E
Ann Intern Med; 1994 Jun; 120(12):993-8. PubMed ID: 8185148
[TBL] [Abstract][Full Text] [Related]
28. Case report: acute polymyositis in a patient with chronic graft vs. host disease.
Ascensao JL; Mascarenhas RB; Mittelman A; Ahmed T
Med Oncol Tumor Pharmacother; 1992; 9(3):149-50. PubMed ID: 1341326
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré syndrome as leading manifestation of graft-versus-host disease in an allogeneic bone marrow transplanted patient.
Thöne J; Lamprecht S; Hohaus A; Erbguth F; Bickel A
J Neurol Sci; 2010 May; 292(1-2):114-6. PubMed ID: 20163810
[TBL] [Abstract][Full Text] [Related]
30. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
Kikuta A; Suzuki H
Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
[TBL] [Abstract][Full Text] [Related]
31. Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease.
Leblond V; Zouabi H; Sutton L; Guillon JM; Mayaud CM; Similowski T; Beigelman C; Autran B
Am J Respir Crit Care Med; 1994 Oct; 150(4):1056-61. PubMed ID: 7921436
[TBL] [Abstract][Full Text] [Related]
32. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.
Oliveira JS; Bahia D; Franco M; Balda C; Stella S; Kerbauy J
Bone Marrow Transplant; 1999 Jan; 23(1):99-101. PubMed ID: 10037059
[TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sõhngen D; Heyll A; Meckenstock G; Aul C; Wolf HH; Schneider W; Specker C; Withold W
Am J Hematol; 1994 Oct; 47(2):143-4. PubMed ID: 8092133
[No Abstract] [Full Text] [Related]
34. Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.
Kennedy MS; Deeg HJ; Storb R; Doney K; Sullivan KM; Witherspoon RP; Appelbaum FR; Stewart P; Sanders J; Buckner CD
Am J Med; 1985 Jun; 78(6 Pt 1):978-83. PubMed ID: 3893112
[TBL] [Abstract][Full Text] [Related]
35. Granulomatous Myositis as a Manifestation of Chronic Graft-Versus-Host Disease: A Case Series and Review of the Literature.
Roy C; Lai EJ; Lee AHA; Schutz P; Maguire J; Toze CL; Nevill TJ; Abou Mourad YR
Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):e459-e462. PubMed ID: 35074288
[No Abstract] [Full Text] [Related]
36. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
37. Sclerodermatous changes of chronic graft-versus-host-disease treated with puva.
Woscoff A; Ruíz Lascano A; De Pablo AB; Robinson A
Int J Dermatol; 1996 Sep; 35(9):656-8. PubMed ID: 8876297
[No Abstract] [Full Text] [Related]
38. The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation.
Terdiman JP; Linker CA; Ries CA; Damon LE; Rugo HS; Ostroff JW
Endoscopy; 1996 Oct; 28(8):680-5. PubMed ID: 8934085
[TBL] [Abstract][Full Text] [Related]
39. Esophageal cast: a manifestation of graft-versus-host disease.
Nakshabendi IM; Maldonado ME; Coppola D; Mamel JJ
Dig Dis; 2000; 18(2):103-5. PubMed ID: 11060473
[TBL] [Abstract][Full Text] [Related]
40. A case of inflammatory myopathy in graft vs host disease - A potential role for ibrutinib.
Wilkinson M; Yeung D; Limaye V
Neuromuscul Disord; 2021 Sep; 31(9):865-869. PubMed ID: 34334272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
